aldosterone has been researched along with Ascites in 202 studies
Ascites: Accumulation or retention of free fluid within the peritoneal cavity.
Excerpt | Relevance | Reference |
---|---|---|
"Adding rifaximin and midodrine to DT enhanced diuresis in refractory ascites with improved systemic, renal hemodynamics and short-term survival." | 9.22 | Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival. ( Hanafy, AS; Hassaneen, AM, 2016) |
"Ninety cirrhotic patients with ascites were studied after administration of HSS infusion (n=25) or etilefrine tablets (n=25), or both (n=25) plus standard diuretics therapy (SDT), or SDT alone (n=15)." | 8.12 | Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites. ( Badra, G; El-Haggar, S; El-Said, H; Ibrahim, O; Radwan, H, 2022) |
"The plasma levels of atrial natriuretic factor in liver cirrhosis can be affected by various factors, such as ascites, renal function, use of diuretics drugs and dietary sodium intake." | 7.68 | Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis. ( Badalamenti, S; Dioguardi, N; Incerti, P; Lorenzano, E; Moser, P; Salerno, F, 1990) |
"Renal tubular sodium handling was evaluated in 27 non-azotemic cirrhotic patients with ascites and positive sodium balance and in 17 controls after at least 5 days of a constant sodium intake using the lithium clearance as an index of fluid delivery to the distal tubule." | 7.68 | Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. ( Angeli, P; Caregaro, L; de Toni, R; Gatta, A; Menon, F; Merkel, C; Rondana, M; Ruol, A; Sacerdoti, D, 1990) |
"We have previously shown that unresponsiveness to atrial natriuretic factor is a marker of the severity of ascites." | 7.68 | Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol. ( Blendis, LM; Morali, GA; Skorecki, KL; Tobe, SW, 1992) |
"Cirrhotic patients with ascites refractory to diuretics also have blunted response to marked elevations of plasma atrial natriuretic factor levels alone or to moderate intravascular volume expansion by head-out water immersion." | 7.68 | Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. ( Blendis, LM; Legault, L; Logan, AG; Skorecki, K; Tobe, S; Wong, F, 1993) |
"Plasma renin activity (PRA), and concentrations of aldosterone (PAL) and arginine vasopressin (AVP) in plasma were determined in 15 patients with ascites due to cirrhosis." | 7.67 | Renin, aldosterone and arginine vasopressin in patients with liver cirrhosis: the influence of ascites retransfusion. ( Burmeister, P; Diener, W; Gerok, W; Schölmerich, J, 1986) |
"kg body wt for 45 min) of synthetic human atrial natriuretic factor (hANF) on renal hemodynamics and the renin-angiotensin-aldosterone system in 15 cirrhotic patients with ascites." | 7.67 | Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. ( Baldi, E; Cominelli, F; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E; Pinzani, M; Renzi, D, 1989) |
"Plasma immunoreactive atrial natriuretic factor (irANF) levels and the effects of alpha-human ANF (alpha-hANF) infusion were investigated in 7 patients with liver cirrhosis and ascites." | 7.67 | Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites. ( Beretta-Piccoli, C; Ferrier, C; Gnädinger, MP; Saxenhofer, H; Shaw, S; Suchecka-Rachon, K; Weidmann, P, 1989) |
"Human atrial natriuretic factor (ANF) levels were measured before and after peritoneovenous shunt implantation in 10 cirrhotic patients with ascites, in whom sodium retention is a major clinical problem." | 7.67 | Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation. ( Hartter, E; Klepetko, W; Miholics, J; Moeschl, P; Müller, C; Schwarz, C; Woloszczuk, W, 1988) |
"Seven patients with persistent hyponatremia but normal or elevated serum arginine vasopressin levels and refractory ascites undergoing peritoneovenous shunting were studied in a Metabolic Unit on a 20 mEq sodium 1200 ml fluid-restricted diet to elucidate the mechanism of this response." | 7.66 | Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting. ( Blendis, LM; Langer, B; Reznick, RK; Seif, S; Taylor, BR, 1983) |
"Thirteen of 15 patients with malignant ascites achieved an excellent response to spironolactone, with an increase in urinary sodium excretion rates from less than 35 mEq/d before treatment to between 50 and 245 mEq/d after treatment." | 7.66 | Control of malignant ascites with spironolactone. ( Greenway, B; Johnson, PJ; Williams, R, 1982) |
"Twenty patients with cirrhosis and ascites but no renal failure were given piretanide, a new loop diuretic, in order to investigate its efficacy and to relate the diuretic response with the pretreatment plasma aldosterone concentration." | 7.66 | Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. ( Arroyo, V; Bosch, J; Cabrera, J; Casamitjana, R; Rivera, F; Rodés, J, 1980) |
"[1-Sarcosine, 8-Isoleucine] angiotensin II was given to 8 patients with cirrhosis and ascites and 7 cirrhotic patients without ascites on a regular diet." | 7.66 | Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites. ( Hata, T; Kumahara, Y; Mandai, T; Mikami, H; Nakamaru, M; Ogihara, T, 1979) |
" Midodrine and octreotide were dosed to obtain a stable increase of at least 15 mm Hg of mean arterial pressure." | 6.69 | Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. ( Amodio, P; Angeli, P; Caregaro, L; Craighero, R; Gatta, A; Gerunda, G; Maffei-Faccioli, A; Merenda, R; Roner, P; Sticca, A; Volpin, R, 1999) |
"Decompensated liver cirrhosis is characterized by activation of the renin-angiotensin-aldosterone system (RAAS)." | 5.35 | Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. ( Boomsma, F; Danser, AH; de Man, R; Kuiper, JJ; van Buren, H; van den Meiracker, AH, 2008) |
"Taurine is a non-protein sulfur amino acid widely distributed in mammalian tissues, with poorly understood functions." | 5.29 | Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. ( Angelico, M; Bologna, E; Gentile, S; Terracina, D, 1994) |
"Thirty-seven patients with liver cirrhosis (16 without ascites: group 1; 21 with untreated ascites at the first onset: group 2) were studied during controlled sodium intake (40 mmol/day)." | 5.27 | Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. ( Bernardi, M; De Palma, R; Gasbarrini, G; Santini, C; Trevisani, F, 1983) |
" A simple clinical method using the urinary Na/K ratio as a guide to spironolactone dosage is outlined." | 5.25 | Spironolactone diuresis in patients with cirrhosis and ascites. ( Eggert, RC, 1970) |
"Adding rifaximin and midodrine to DT enhanced diuresis in refractory ascites with improved systemic, renal hemodynamics and short-term survival." | 5.22 | Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival. ( Hanafy, AS; Hassaneen, AM, 2016) |
"This pilot study suggests that midodrine is not as effective as intravenous albumin in preventing circulatory dysfunction after large-volume paracentesis in patients with cirrhosis and tense ascites, especially with HCC-positive patients." | 5.19 | Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study. ( ElBaz, AA; Hamdy, H; Hassan, A; Hassanin, O, 2014) |
"This pilot study suggests that midodrine is not as effective as albumin in preventing circulatory dysfunction after large-volume paracentesis in patients with cirrhosis and ascites." | 5.13 | Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. ( Appenrodt, B; Grünhage, F; Heller, J; Lammert, F; Rabe, C; Sauerbruch, T; Schepke, M; Trebicka, J; Wolf, A, 2008) |
"Forty patients with cirrhosis and tense ascites underwent therapeutic paracentesis with albumin or terlipressin in a randomized pilot study at a tertiary center." | 5.12 | Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. ( Kumar, R; Nain, CK; Sharma, AK; Singh, B; Singh, V, 2006) |
"Twenty nonazotemic cirrhotic patients with ascites were treated with furosemide and spironolactone." | 5.12 | The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. ( Economou, M; Kalambokis, G; Kosta, P; Papadimitriou, K; Tsianos, EV, 2006) |
"Five patients (three in the placebo and two in the spironolactone group) abandoned the treatment prior to ascites recurrence or the end of the study due to complications or lack of compliance." | 5.08 | Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. ( Adler, M; Arroyo, V; Elewaut, A; Fernández-Esparrach, G; Geuvel, A; Ginès, P; Guevara, M; Jiménez, W; Lebrec, D; Pardo, A; Planas, R; Sort, P, 1997) |
"Ninety cirrhotic patients with ascites were studied after administration of HSS infusion (n=25) or etilefrine tablets (n=25), or both (n=25) plus standard diuretics therapy (SDT), or SDT alone (n=15)." | 4.12 | Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites. ( Badra, G; El-Haggar, S; El-Said, H; Ibrahim, O; Radwan, H, 2022) |
"Patients with cirrhosis and refractory ascites without renal dysfunction had systemic hemodynamics, renal function, and neurohormones (plasma active renin, aldosterone, norepinephrine and angiotensin II) measured pre- and 6 days post-paracentesis." | 3.83 | Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study. ( James, PD; Tan, HK; Wong, F, 2016) |
"The plasma levels of atrial natriuretic factor in liver cirrhosis can be affected by various factors, such as ascites, renal function, use of diuretics drugs and dietary sodium intake." | 3.68 | Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis. ( Badalamenti, S; Dioguardi, N; Incerti, P; Lorenzano, E; Moser, P; Salerno, F, 1990) |
"We have previously shown that unresponsiveness to atrial natriuretic factor is a marker of the severity of ascites." | 3.68 | Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol. ( Blendis, LM; Morali, GA; Skorecki, KL; Tobe, SW, 1992) |
"Cirrhotic patients with ascites refractory to diuretics also have blunted response to marked elevations of plasma atrial natriuretic factor levels alone or to moderate intravascular volume expansion by head-out water immersion." | 3.68 | Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. ( Blendis, LM; Legault, L; Logan, AG; Skorecki, K; Tobe, S; Wong, F, 1993) |
" the main representatives of sodium retaining systems, and of the atrial natriuretic factor (ANF) the decisive natriuretic substance in acute expansion of the extracellular volume (ECV) by infusion of two litres of saline in six controls, seven patients with essential hypertension and liver cirrhosis without ascites (6 patients) and with ascites (6 patients)." | 3.68 | [Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading]. ( Dvoráková, J; Gregorová, I; Horký, K; Srámková, J; Tesar, V, 1990) |
"Renal tubular sodium handling was evaluated in 27 non-azotemic cirrhotic patients with ascites and positive sodium balance and in 17 controls after at least 5 days of a constant sodium intake using the lithium clearance as an index of fluid delivery to the distal tubule." | 3.68 | Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. ( Angeli, P; Caregaro, L; de Toni, R; Gatta, A; Menon, F; Merkel, C; Rondana, M; Ruol, A; Sacerdoti, D, 1990) |
"Plasma immunoreactive atrial natriuretic factor (irANF) levels and the effects of alpha-human ANF (alpha-hANF) infusion were investigated in 7 patients with liver cirrhosis and ascites." | 3.67 | Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites. ( Beretta-Piccoli, C; Ferrier, C; Gnädinger, MP; Saxenhofer, H; Shaw, S; Suchecka-Rachon, K; Weidmann, P, 1989) |
"kg body wt for 45 min) of synthetic human atrial natriuretic factor (hANF) on renal hemodynamics and the renin-angiotensin-aldosterone system in 15 cirrhotic patients with ascites." | 3.67 | Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. ( Baldi, E; Cominelli, F; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E; Pinzani, M; Renzi, D, 1989) |
"Human atrial natriuretic factor (ANF) levels were measured before and after peritoneovenous shunt implantation in 10 cirrhotic patients with ascites, in whom sodium retention is a major clinical problem." | 3.67 | Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation. ( Hartter, E; Klepetko, W; Miholics, J; Moeschl, P; Müller, C; Schwarz, C; Woloszczuk, W, 1988) |
"Plasma renin activity (PRA), and concentrations of aldosterone (PAL) and arginine vasopressin (AVP) in plasma were determined in 15 patients with ascites due to cirrhosis." | 3.67 | Renin, aldosterone and arginine vasopressin in patients with liver cirrhosis: the influence of ascites retransfusion. ( Burmeister, P; Diener, W; Gerok, W; Schölmerich, J, 1986) |
"[1-Sarcosine, 8-Isoleucine] angiotensin II was given to 8 patients with cirrhosis and ascites and 7 cirrhotic patients without ascites on a regular diet." | 3.66 | Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites. ( Hata, T; Kumahara, Y; Mandai, T; Mikami, H; Nakamaru, M; Ogihara, T, 1979) |
"Plasma renin activity (PRA), plasma renin concentration (PRC), angiotensinogen, angiotensin II (AT II) and plasma aldosterone were determined by radioimmunoassay in 77 patients with cirrhosis of the liver [group I: with ascites, untreated (n=23); group II: patients with ascites during treatment (n=32); group III: after removal of fluids, but under further spironolactone therapy (n=10); group IV: untreated subjects without ascites (n=12)]." | 3.66 | Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. ( Müller, G; Spech, HJ; Wernze, H, 1978) |
"Twenty patients with cirrhosis and ascites but no renal failure were given piretanide, a new loop diuretic, in order to investigate its efficacy and to relate the diuretic response with the pretreatment plasma aldosterone concentration." | 3.66 | Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. ( Arroyo, V; Bosch, J; Cabrera, J; Casamitjana, R; Rivera, F; Rodés, J, 1980) |
" Patients with edema, ascites, or both had significantly greater elevation of plasma aldosterone levels compared to nonedematous patients; these patients also demonstrated a substantial degree of hepatic dysfunction as evidenced by lower serum albumin levels and higher bilirubin and alkaline phosphatase levels." | 3.66 | Hyperaldosteronism associated with liver metastases. ( Citrin, DL; Crowley, J; Pandya, KJ; Whitehead, R, 1980) |
"Thirteen of 15 patients with malignant ascites achieved an excellent response to spironolactone, with an increase in urinary sodium excretion rates from less than 35 mEq/d before treatment to between 50 and 245 mEq/d after treatment." | 3.66 | Control of malignant ascites with spironolactone. ( Greenway, B; Johnson, PJ; Williams, R, 1982) |
"Seven patients with persistent hyponatremia but normal or elevated serum arginine vasopressin levels and refractory ascites undergoing peritoneovenous shunting were studied in a Metabolic Unit on a 20 mEq sodium 1200 ml fluid-restricted diet to elucidate the mechanism of this response." | 3.66 | Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting. ( Blendis, LM; Langer, B; Reznick, RK; Seif, S; Taylor, BR, 1983) |
"An angiotensin II antagonist, [1-sarcosine, 8-alanine]-angiotensin II, was given intravenously to anesthetized dogs with thoracic caval constriction and ascites to investigate the role of angiotensin II in the control of arterial pressure." | 3.65 | Angiotensin. II. Important role in the maintenance of arterial blood pressure. ( Davis, JO; Johnson, JA, 1973) |
"The effects of water diuresis, hypotonic NaCl, and hypotonic mannitol diuresis on renal sodium and water excretion were examined in normal dogs and in dogs with chronic constriction of the thoracic inferior vena cava and ascites (caval dogs)." | 3.65 | Increased sodium reabsorption in the proximal and distal tubule of caval dogs. ( Cacciaguida, RJ; Kaloyanides, GJ; Pablo, NC; Porush, JG, 1969) |
"Treatment with midodrine and albumin was associated with a slight but significant decrease in plasma renin activity and aldosterone compared to placebo (renin -4." | 2.87 | Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. ( Ariza, X; Castellote, J; Colmenero, J; Córdoba, J; de Prada, G; Fabrellas, N; Garcia-Martínez, R; Ginès, P; Graupera, I; Guevara, M; Huelin, P; Lopez Benaiges, E; Manríquez, M; Márquez, F; Martín-Llahí, M; Moreira, R; Navasa, M; Nazar, A; Pavesi, M; Pose, E; Simón-Talero, M; Solà, E; Solé, C; Suñé, P; Torrens, M; Vargas, V; Ventura, M; Xiol, X, 2018) |
" Midodrine and octreotide were dosed to obtain a stable increase of at least 15 mm Hg of mean arterial pressure." | 2.69 | Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. ( Amodio, P; Angeli, P; Caregaro, L; Craighero, R; Gatta, A; Gerunda, G; Maffei-Faccioli, A; Merenda, R; Roner, P; Sticca, A; Volpin, R, 1999) |
"In patients with congestive heart failure treated with digitalis, these natriuretic agents are particularly useful because of their potassium-sparing properties." | 2.37 | Clinical applications of antimineralocorticoids. ( Brunner, HR; Nüssberger, J; Waeber, B, 1988) |
"Decompensated liver cirrhosis is characterized by activation of the renin-angiotensin-aldosterone system (RAAS)." | 1.35 | Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. ( Boomsma, F; Danser, AH; de Man, R; Kuiper, JJ; van Buren, H; van den Meiracker, AH, 2008) |
"In patients with liver cirrhosis and ascites, amino acid infusion improves kidney function." | 1.31 | Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites. ( Brensing, KA; Flommersfeld, S; Sauerbruch, T; Schiedermaier, P; Spengler, U; Stoffel-Wagner, B; Woitas, RP, 2002) |
"However, new-onset or worsening hepatic encephalopathy was seen in 14 patients." | 1.30 | Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution. ( Dufresne, MP; Fenyves, D; Lafortune, M; Legault, L; Martinet, JP; Pomier-Layrargues, G; Roy, L; Spahr, L, 1997) |
"Taurine is a non-protein sulfur amino acid widely distributed in mammalian tissues, with poorly understood functions." | 1.29 | Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. ( Angelico, M; Bologna, E; Gentile, S; Terracina, D, 1994) |
"The patients affected by liver cirrhosis without ascites showed PRA and PA levels similar to those observed in the control group, while ANP plasma levels were significantly higher (50." | 1.29 | [ANP in the cirrhotic patient. A clinical contribution]. ( Baccarini, S; Cervellini, P; Di Nardo, A; La Torre, F; Labellarte, A; Paparo, SB; Parlapiano, C; Primi, F, 1994) |
" Aprotinin was infused intravenously in high dosage (2 x 10(6) kallikrein inhibitory units loading, 1 x 10(6) kallikrein inhibitory units/h)." | 1.29 | Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. ( Craig, KJ; Cumming, AD; Hayes, PC; MacGilchrist, A, 1994) |
"Aldosterone was elevated in the unilateral group and markedly elevated in the bilateral group." | 1.29 | The hyponatremia of neonatal urinary ascites: clinical observations, experimental confirmation and proposed mechanism. ( Clarke, HS; Kropp, KA; Mills, ME; Parres, JA, 1993) |
"It has been proposed that in liver cirrhosis portal hypertension causes splanchnic vasodilation and this induces blood volume expansion to maintain blood pressure." | 1.28 | Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis. ( Díez, J; Prieto, J; Simón, MA, 1991) |
"In 20 patients with advanced liver cirrhosis and ascites the aldosterone level in the blood plasma and in the ascitic fluid was higher than in the healthy controls." | 1.28 | [The clinical importance of determining aldosterone in the ascitic fluid]. ( Aleksiev, A; Konstantinova, N; Maleeva, A; Stanchev, N, 1990) |
"Twenty patients with liver cirrhosis and refractory ascites were studied before and during extraction-concentration-reinfusion (ECR) of ascitic fluid by means of Rhodiascit." | 1.28 | [Changes in antidiuretic hormone (ADH) in liver cirrhosis with resistant ascites]. ( Barbetti, V; Cattana, A; Colombo, P; Folco, U; Giudici Cipriani, A; Marenco, G; Menardo, G; Rembado, R, 1989) |
"Thirty-seven patients with liver cirrhosis (16 without ascites: group 1; 21 with untreated ascites at the first onset: group 2) were studied during controlled sodium intake (40 mmol/day)." | 1.27 | Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. ( Bernardi, M; De Palma, R; Gasbarrini, G; Santini, C; Trevisani, F, 1983) |
"Secondary aldosteronism in connection with decompensated cirrhosis of the liver arises mainly under therapy with diuretics." | 1.26 | [What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?]. ( Albert, JP; Hartmann, F, 1981) |
" A simple clinical method using the urinary Na/K ratio as a guide to spironolactone dosage is outlined." | 1.25 | Spironolactone diuresis in patients with cirrhosis and ascites. ( Eggert, RC, 1970) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 130 (64.36) | 18.7374 |
1990's | 49 (24.26) | 18.2507 |
2000's | 13 (6.44) | 29.6817 |
2010's | 7 (3.47) | 24.3611 |
2020's | 3 (1.49) | 2.80 |
Authors | Studies |
---|---|
Prasad, D | 1 |
Sen Sarma, M | 1 |
Yachha, SK | 1 |
Prasad, R | 1 |
Srivastava, A | 1 |
Poddar, U | 1 |
Kumar, A | 1 |
Radwan, H | 1 |
Ibrahim, O | 1 |
Badra, G | 1 |
El-Said, H | 1 |
El-Haggar, S | 1 |
Tripathy, A | 1 |
Maiti, R | 1 |
Jena, M | 1 |
Mishra, A | 1 |
Srinivasan, A | 1 |
Solà, E | 1 |
Solé, C | 1 |
Simón-Talero, M | 1 |
Martín-Llahí, M | 1 |
Castellote, J | 1 |
Garcia-Martínez, R | 1 |
Moreira, R | 1 |
Torrens, M | 1 |
Márquez, F | 1 |
Fabrellas, N | 1 |
de Prada, G | 1 |
Huelin, P | 1 |
Lopez Benaiges, E | 1 |
Ventura, M | 1 |
Manríquez, M | 1 |
Nazar, A | 1 |
Ariza, X | 1 |
Suñé, P | 1 |
Graupera, I | 1 |
Pose, E | 1 |
Colmenero, J | 1 |
Pavesi, M | 1 |
Guevara, M | 3 |
Navasa, M | 1 |
Xiol, X | 1 |
Córdoba, J | 1 |
Vargas, V | 2 |
Ginès, P | 8 |
Hamdy, H | 1 |
ElBaz, AA | 1 |
Hassan, A | 1 |
Hassanin, O | 1 |
Liu, HY | 1 |
Zhong, GS | 1 |
Liu, YX | 1 |
Wang, X | 1 |
Ou, LN | 1 |
Liu, J | 1 |
Chen, SH | 1 |
Gao, Y | 1 |
Gamblin, V | 1 |
Da Silva, A | 1 |
Villet, S | 1 |
El Hajbi, F | 1 |
Tan, HK | 1 |
James, PD | 1 |
Wong, F | 7 |
Hanafy, AS | 1 |
Hassaneen, AM | 1 |
Kuiper, JJ | 1 |
Boomsma, F | 1 |
van Buren, H | 1 |
de Man, R | 1 |
Danser, AH | 1 |
van den Meiracker, AH | 1 |
Yang, YY | 1 |
Lin, HC | 2 |
Lin, MW | 1 |
Chu, CJ | 1 |
Lee, FY | 2 |
Hou, MC | 2 |
Lee, SD | 2 |
Lee, WP | 1 |
Liu, TT | 1 |
Jap, TS | 1 |
Woitas, RP | 1 |
Flommersfeld, S | 1 |
Stoffel-Wagner, B | 1 |
Schiedermaier, P | 1 |
Brensing, KA | 1 |
Spengler, U | 1 |
Sauerbruch, T | 2 |
Blei, AT | 1 |
Blendis, LM | 10 |
Thuluvath, PJ | 1 |
BEAULIEU, EE | 2 |
FUNEL, P | 2 |
LEMONNIER, F | 2 |
VESIN, P | 2 |
SUMMERSKILL, WH | 3 |
CRABBE, J | 2 |
DAVIS, JO | 4 |
BALL, WC | 1 |
KERR, DN | 1 |
READ, AE | 1 |
HASLAM, RM | 1 |
SHERLOCK, S | 2 |
OLIVER, E | 1 |
STORMONT, JM | 1 |
FAST, B | 1 |
WOLFE, SJ | 1 |
DAVIDSON, CS | 1 |
HOLUB, DA | 1 |
JAILER, JW | 1 |
LEVRAT, M | 1 |
BRETTE, R | 1 |
FRANCOIS, B | 1 |
TISSOT, A | 1 |
MESTRALLET, G | 1 |
LOCKWOOD, CH | 1 |
MORRISON, RS | 1 |
CHALMERS, TC | 1 |
EDMONDS, CJ | 1 |
BONINI, A | 1 |
CHEY, WY | 1 |
SHAY, H | 1 |
van DOMMELEN, C | 1 |
LE POOLE, A | 1 |
VAANDRAGER, H | 1 |
SCHOPMAN, W | 1 |
WADMAN, SK | 1 |
CLOWDUS, BF | 1 |
ROSEVEAR, JW | 1 |
VELASCO, M | 1 |
GAZMURI, R | 1 |
KATZ, R | 1 |
GANTT, CL | 1 |
ECKLUND, RE | 1 |
RIVERA, A | 1 |
SEPULVEDA, B | 1 |
LANDA, L | 1 |
CHAGOYA, L | 1 |
RUBEGNI, M | 1 |
RAVENNI, G | 1 |
FORCONI, S | 1 |
FISHER, ER | 1 |
KLEIN, HZ | 1 |
PILIEGO, N | 1 |
ROSSINI, P | 1 |
DELZOTTI, G | 1 |
CURCIO, R | 1 |
CASSIA, B | 1 |
ARMASCRUZ, R | 1 |
GOMEZ, R | 1 |
MARDONES, J | 1 |
PLAZADELOSREYES, M | 1 |
HOFFMEISTER, W | 1 |
ARGUEELLES, AE | 1 |
CHEKHERDEMIAN, M | 1 |
MUNIAGURRIA, JL | 1 |
RICCA, A | 1 |
ORLOFF, MJ | 1 |
ROSS, TH | 1 |
BADDELEY, RM | 1 |
NUTTING, RO | 1 |
SPITZ, BR | 1 |
SLOOP, RD | 1 |
NEESBY, T | 1 |
HALASZ, NA | 1 |
PETERMANN, CP | 1 |
FRANCE, CJ | 1 |
COOPER, RR | 1 |
STEVENS, DF | 1 |
PINCUS, G | 1 |
JACONO, A | 1 |
BUONINCONTI, R | 1 |
VITALE, P | 1 |
WAHI, PN | 2 |
BODKHE, RR | 2 |
WAHAL, PK | 2 |
BOJS, GE | 1 |
CONN, HL | 1 |
HORKY, K | 3 |
KUECHEL, O | 1 |
PAZOUREK, M | 1 |
BANSAL, OP | 1 |
LAHIRI, B | 1 |
AMES, RP | 1 |
BORKOWSKI, AJ | 1 |
SICINSKI, AM | 1 |
LARAGH, JH | 2 |
HENLEY, KS | 1 |
STREETEN, DH | 1 |
POLLARD, HM | 1 |
SHALDON, S | 1 |
McLAREN, JR | 1 |
MINICONI, P | 1 |
BOURREILLE, J | 1 |
SUDUCA, P | 1 |
CARAYON, P | 1 |
LAVOCAT, G | 1 |
ISSAD, H | 1 |
OFSTAD, J | 1 |
SIGSTAD, H | 1 |
Coll, S | 3 |
Vila, MC | 3 |
Molina, L | 2 |
Gimenez, MD | 1 |
Guarner, C | 2 |
Solà, R | 3 |
Pantea, L | 1 |
Sniderman, K | 1 |
Singh, V | 1 |
Kumar, R | 1 |
Nain, CK | 1 |
Singh, B | 1 |
Sharma, AK | 1 |
Kalambokis, G | 1 |
Economou, M | 1 |
Kosta, P | 1 |
Papadimitriou, K | 1 |
Tsianos, EV | 1 |
Appenrodt, B | 1 |
Wolf, A | 1 |
Grünhage, F | 1 |
Trebicka, J | 1 |
Schepke, M | 1 |
Rabe, C | 1 |
Lammert, F | 1 |
Heller, J | 2 |
Tandon, P | 1 |
Tsuyuki, RT | 1 |
Mitchell, L | 1 |
Hoskinson, M | 1 |
Ma, MM | 1 |
Wong, WW | 1 |
Mason, AL | 1 |
Gutfreund, K | 1 |
Bain, VG | 1 |
Earley, LE | 2 |
Witte, MH | 2 |
Levine, N | 1 |
Dumont, AE | 1 |
Yang, JS | 1 |
Fu, S | 1 |
Yang, YQ | 1 |
Qian, YD | 1 |
Yu, ZP | 1 |
Xu, RG | 1 |
Jin, JP | 1 |
Jiang, JM | 1 |
Reznick, RK | 1 |
Langer, B | 4 |
Taylor, BR | 4 |
Seif, S | 1 |
Bernardi, M | 5 |
Trevisani, F | 4 |
Santini, C | 2 |
De Palma, R | 1 |
Gasbarrini, G | 4 |
Chmielewska, J | 1 |
Sewell, RB | 1 |
Poston, L | 1 |
Wilkinson, SP | 4 |
Bichet, DG | 1 |
Van Putten, VJ | 1 |
Schrier, RW | 3 |
Tang, ZD | 1 |
Kuntz, E | 1 |
Martin, A | 1 |
Sturniolo, GC | 1 |
Naccarato, R | 1 |
Gonvers, JJ | 2 |
Loup, P | 2 |
Hofstetter, JR | 2 |
Brunner, HR | 3 |
Williams, R | 4 |
Greig, PD | 3 |
Colapinto, RF | 1 |
Arroyo, V | 10 |
Bosch, J | 4 |
Gaya-Beltrán, J | 1 |
Kravetz, D | 1 |
Estrada, L | 1 |
Rivera, F | 5 |
Rodés, J | 5 |
Mosimann, R | 1 |
Ruse, J | 2 |
Greenway, B | 1 |
Johnson, PJ | 1 |
Pini, P | 1 |
Turci, P | 1 |
Albert, JP | 2 |
Hartmann, F | 2 |
Pandya, KJ | 1 |
Whitehead, R | 1 |
Crowley, J | 1 |
Citrin, DL | 1 |
Casamitjana, R | 1 |
Cabrera, J | 1 |
Andreu, M | 2 |
Oliver, MI | 1 |
Gana, J | 2 |
Ledesma, S | 1 |
Jiménez, W | 5 |
MacGilchrist, A | 1 |
Craig, KJ | 1 |
Hayes, PC | 1 |
Cumming, AD | 1 |
Jespersen, B | 1 |
Eiskjaer, H | 1 |
Jensen, JD | 1 |
Mogensen, CE | 1 |
Sørensen, SS | 1 |
Pedersen, EB | 1 |
Fornalè, L | 1 |
Di Marco, C | 1 |
Gasbarrini, A | 2 |
Baraldini, M | 1 |
Ligabue, A | 1 |
Quiroga, J | 1 |
Sangro, B | 1 |
Núñez, M | 1 |
Bilbao, I | 1 |
Longo, J | 1 |
García-Villarreal, L | 1 |
Zozaya, JM | 1 |
Betés, M | 1 |
Herrero, JI | 1 |
Prieto, J | 2 |
Parlapiano, C | 1 |
Labellarte, A | 1 |
Primi, F | 1 |
Cervellini, P | 1 |
La Torre, F | 1 |
Paparo, SB | 1 |
Baccarini, S | 1 |
Di Nardo, A | 1 |
Somberg, KA | 1 |
Lake, JR | 1 |
Tomlanovich, SJ | 1 |
LaBerge, JM | 1 |
Feldstein, V | 1 |
Bass, NM | 1 |
Van Vliet, AA | 1 |
Kröger, R | 1 |
Dubbelman, R | 1 |
Ten Bokkel-Huinink, WW | 1 |
Rimondi, A | 1 |
Caraceni, P | 1 |
Legnani, C | 1 |
Palareti, G | 1 |
Pozzi, M | 1 |
Osculati, G | 1 |
Boari, G | 1 |
Serboli, P | 1 |
Colombo, P | 2 |
Lambrughi, C | 1 |
De Ceglia, S | 1 |
Roffi, L | 1 |
Piperno, A | 1 |
Cusa, EN | 1 |
Gentile, S | 3 |
Bologna, E | 2 |
Terracina, D | 1 |
Angelico, M | 3 |
García-Compeán, D | 1 |
Zacarías Villarreal, J | 1 |
Bahena Cuevas, H | 1 |
García Cantú, DA | 1 |
Estrella, M | 1 |
Garza Tamez, E | 1 |
Valadez Castillo, R | 1 |
Barragán, RF | 1 |
Angeli, P | 5 |
Dalla Pria, M | 1 |
De Bei, E | 1 |
Albino, G | 1 |
Caregaro, L | 4 |
Merkel, C | 3 |
Ceolotto, G | 1 |
Gatta, A | 4 |
Liu, P | 2 |
Tobe, S | 3 |
Morali, G | 1 |
Blendis, L | 2 |
Clarke, HS | 1 |
Mills, ME | 1 |
Parres, JA | 1 |
Kropp, KA | 1 |
Legault, L | 3 |
Logan, AG | 2 |
Skorecki, K | 1 |
Messa, P | 1 |
Cannella, G | 1 |
Mioni, G | 1 |
Boscutti, G | 1 |
Messa, M | 1 |
De Biasi, F | 1 |
Cioni, A | 1 |
Salmerón, JM | 2 |
Ruiz del Arbol, L | 1 |
Ginès, A | 4 |
García-Pagán, JC | 1 |
Feu, F | 1 |
Claria, J | 2 |
Gülberg, V | 1 |
Gerbes, AL | 1 |
Tsai, YT | 1 |
Wang, SS | 1 |
Saló, J | 2 |
Kuhn, M | 1 |
Fernández-Esparrach, G | 3 |
Bataller, R | 1 |
Forssmann, WG | 1 |
Martinet, JP | 1 |
Fenyves, D | 2 |
Roy, L | 2 |
Dufresne, MP | 2 |
Spahr, L | 2 |
Lafortune, M | 2 |
Pomier-Layrargues, G | 2 |
Peltekian, KM | 1 |
Liu, PP | 1 |
Sherman, M | 1 |
Sort, P | 2 |
Pardo, A | 1 |
Planas, R | 2 |
Lebrec, D | 2 |
Geuvel, A | 1 |
Elewaut, A | 1 |
Adler, M | 1 |
La Villa, G | 3 |
Lazzeri, C | 1 |
Pascale, A | 1 |
Sestini, S | 1 |
Bisi, G | 1 |
Sciagrà, R | 1 |
Vecchiarino, S | 1 |
Raggi, VC | 1 |
Barletta, G | 1 |
Laffi, G | 3 |
Gentilini, P | 3 |
Fábrega, E | 1 |
Casafont, F | 1 |
Crespo, J | 1 |
de la Peña, J | 1 |
San Miguel, G | 1 |
de las Heras, G | 1 |
García-Unzueta, MT | 1 |
Amado, JA | 1 |
Pons-Romero, F | 1 |
Martin, PY | 1 |
Ohara, M | 1 |
Xu, DL | 1 |
St John, J | 1 |
Niederberger, M | 1 |
Marquez, J | 1 |
Palá, J | 1 |
Bory, F | 1 |
Pons, S | 1 |
Szescielinski, L | 1 |
Sàbat, M | 1 |
Soriano, G | 1 |
Bulbena, O | 1 |
Novella, MT | 1 |
Ortiz, J | 1 |
Ricart, E | 1 |
Villanueva, C | 1 |
Rosello, J | 1 |
Rodríguez, J | 1 |
Balanzó, J | 1 |
Veglio, F | 1 |
Melchio, R | 1 |
Calva, S | 1 |
Rabbia, F | 1 |
Gallo, V | 1 |
Molino, P | 1 |
Mengozzi, G | 1 |
Mulatero, P | 1 |
Martini, G | 1 |
Riva, P | 1 |
Chiandussi, L | 1 |
Genesca, J | 1 |
Gonzalez, A | 1 |
Segura, R | 1 |
Catalan, R | 1 |
Marti, R | 1 |
Varela, E | 1 |
Cadelina, G | 1 |
Martinez, M | 1 |
Lopez-Talavera, JC | 1 |
Esteban, R | 1 |
Groszmann, RJ | 1 |
Guardia, J | 1 |
Deschênes, M | 1 |
Bui, B | 1 |
Volpin, R | 1 |
Gerunda, G | 1 |
Craighero, R | 1 |
Roner, P | 1 |
Merenda, R | 1 |
Amodio, P | 1 |
Sticca, A | 1 |
Maffei-Faccioli, A | 1 |
Palmer, BF | 1 |
Knotek, M | 1 |
Rogachev, B | 1 |
Colle, I | 1 |
Moreau, R | 1 |
Pessione, F | 1 |
Rassiat, E | 1 |
Chagneau, C | 1 |
Pateron, D | 1 |
Barrière, E | 1 |
Condat, B | 1 |
Sogni, P | 1 |
Valla, D | 1 |
Lenaerts, A | 1 |
Codden, T | 1 |
Henry, JP | 1 |
Van Cauter, J | 1 |
Meunier, JC | 1 |
Ligny, G | 1 |
Mauri, M | 1 |
Viver, J | 1 |
Mas, A | 1 |
Wernze, H | 3 |
Freeman, RH | 1 |
Williams, GM | 2 |
DeForrest, JM | 1 |
Seymour, AA | 1 |
Rowe, BP | 1 |
Baigrie, RS | 1 |
Zipser, RD | 1 |
Hoefs, JC | 1 |
Speckart, PF | 1 |
Zia, PK | 1 |
Horton, R | 3 |
Hata, T | 1 |
Ogihara, T | 1 |
Mikami, H | 1 |
Nakamaru, M | 1 |
Mandai, T | 1 |
Kumahara, Y | 1 |
Jowett, TP | 1 |
Slater, JD | 2 |
Moodie, H | 1 |
Wronski, R | 1 |
Jentzen, F | 1 |
Wong, PY | 1 |
Carroll, RE | 1 |
Lipinski, TL | 1 |
Capone, RR | 1 |
Witte, CL | 1 |
Jacobs, S | 1 |
Kut, R | 1 |
Levy, M | 3 |
Spech, HJ | 1 |
Müller, G | 1 |
Berkowitz, HD | 1 |
Mullen, JL | 1 |
Miller, LD | 1 |
Rosato, EF | 1 |
Saito, I | 1 |
Saruta, T | 1 |
Eguchi, T | 1 |
Nakamura, R | 1 |
Kondo, K | 1 |
Iyori, S | 1 |
Kato, E | 2 |
Lohmeier, TE | 1 |
Hanson, RC | 1 |
Werning, C | 1 |
Vetter, H | 1 |
Vetter, W | 1 |
Beckerhoff, R | 1 |
Glänzer, K | 1 |
Furrer, J | 1 |
Hahn, C | 1 |
Kolloch, R | 1 |
Krück, F | 1 |
Kutz, K | 1 |
Siegenthaler, W | 1 |
Witassek, F | 1 |
Rosoff, L | 1 |
Zia, P | 1 |
Reynolds, T | 1 |
Panos, MZ | 1 |
Anderson, JV | 1 |
Payne, N | 1 |
Langley, P | 1 |
Rees, L | 1 |
Uchihara, M | 1 |
Izumi, N | 1 |
Sato, C | 1 |
Marumo, F | 1 |
Morali, GA | 2 |
Tobe, SW | 1 |
Skorecki, KL | 2 |
Romanelli, RG | 1 |
Casini Raggi, V | 1 |
Tosti-Guerra, C | 1 |
De Feo, ML | 1 |
Marra, F | 2 |
Llach, J | 1 |
Panés, J | 1 |
Toledo, C | 1 |
Rimola, A | 1 |
Salerno, F | 2 |
Badalamenti, S | 2 |
Lorenzano, E | 2 |
Moser, P | 2 |
Incerti, P | 2 |
Floras, JS | 1 |
Menon, F | 2 |
Sacerdoti, D | 2 |
Simón, MA | 1 |
Díez, J | 1 |
Leehey, DJ | 1 |
Gollapudi, P | 1 |
Deakin, A | 1 |
Reid, RW | 1 |
Maleeva, A | 1 |
Stanchev, N | 1 |
Konstantinova, N | 1 |
Aleksiev, A | 1 |
Rondana, M | 1 |
de Toni, R | 1 |
Ruol, A | 1 |
Dioguardi, N | 1 |
Tesar, V | 2 |
Gregorová, I | 1 |
Srámková, J | 1 |
Dvoráková, J | 1 |
Kozáková, M | 1 |
Petrtýl, J | 1 |
Kordac, V | 1 |
Colantonio, D | 1 |
Pasqualetti, P | 1 |
Casale, R | 1 |
Desiati, P | 1 |
Giandomenico, G | 1 |
Natali, G | 1 |
Ferrier, C | 1 |
Beretta-Piccoli, C | 1 |
Weidmann, P | 1 |
Gnädinger, MP | 1 |
Shaw, S | 1 |
Suchecka-Rachon, K | 1 |
Saxenhofer, H | 1 |
Maher, E | 1 |
Cernacek, P | 1 |
Pinzani, M | 1 |
Meacci, E | 1 |
Renzi, D | 1 |
Baldi, E | 1 |
Cominelli, F | 1 |
Capocaccia, L | 1 |
Marenco, G | 1 |
Giudici Cipriani, A | 2 |
Folco, U | 1 |
Menardo, G | 1 |
Cattana, A | 1 |
Barbetti, V | 1 |
Rembado, R | 1 |
Mansurov, KhKh | 1 |
Dustov, AD | 1 |
Nikolaeva, OS | 1 |
Klepetko, W | 1 |
Müller, C | 1 |
Hartter, E | 1 |
Miholics, J | 1 |
Schwarz, C | 1 |
Woloszczuk, W | 1 |
Moeschl, P | 1 |
Uemasu, J | 1 |
Kawasaki, H | 2 |
Hirayama, C | 2 |
Waeber, B | 1 |
Nüssberger, J | 1 |
Burmeister, P | 1 |
Schölmerich, J | 1 |
Diener, W | 1 |
Gerok, W | 1 |
Murawaki, Y | 1 |
Amerio, A | 1 |
Cananzi, C | 1 |
Zanelli, G | 1 |
Zinicola, N | 1 |
Fajardo, J | 1 |
López-Novoa, JM | 1 |
Escarce, JJ | 1 |
Chiappini, MG | 1 |
Peruzzi, G | 1 |
Vulterini, S | 1 |
Wexler, MJ | 1 |
McCloy, RM | 1 |
Baldus, WP | 2 |
Maher, FT | 1 |
Louis, WJ | 1 |
Doyle, AE | 1 |
Santambrogio, S | 1 |
Natangelo, R | 1 |
Lucchelli, PD | 1 |
Serebrovskaia, IuA | 1 |
Vinogradov, AV | 1 |
Uchitel', IA | 1 |
Daugharty, TM | 1 |
Cannon, PJ | 1 |
Runcan, V | 1 |
Buligescu, L | 2 |
Tutunaru, M | 1 |
Wolański, A | 1 |
Holowiecki, J | 1 |
Machalski, M | 1 |
Kocot, E | 1 |
Nomoto, Y | 1 |
Fichman, MP | 1 |
Littenburg, G | 1 |
Brooker, G | 1 |
Johnson, JA | 1 |
Ito, T | 1 |
Hidaka, H | 1 |
Kato, T | 1 |
Yoshitoski, Y | 1 |
Arbeiter, G | 1 |
Meyer-Burg, J | 1 |
Conn, HO | 1 |
Pearlman, DM | 1 |
Loginov, AS | 1 |
Berezov, VM | 1 |
Liebowitz, HR | 1 |
Inoue, J | 1 |
Mori, Y | 1 |
Kawamura, T | 1 |
Wolfman, EF | 1 |
Kowalczyk, RS | 1 |
Trevino, G | 1 |
Radó, JP | 1 |
Marosi, J | 1 |
Takó, J | 1 |
Dévényi, I | 1 |
Engel, T | 1 |
Jewelewicz, R | 1 |
Dyrenfurth, I | 1 |
Speroff, L | 1 |
Vande Wiele, RL | 1 |
Kubo, S | 1 |
Candiori, R | 1 |
Belleau, L | 1 |
Mion, H | 1 |
Simard, S | 1 |
Granger, P | 1 |
Bertranou, E | 1 |
Nowaczynski, W | 1 |
Boucher, R | 1 |
Genest, J | 1 |
Eggert, RC | 1 |
Clarkson, EM | 1 |
Luck, VA | 1 |
Darnis, F | 1 |
Bull, MB | 1 |
Kaloyanides, GJ | 1 |
Cacciaguida, RJ | 1 |
Pablo, NC | 1 |
Porush, JG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Midodrine and Albumin for Cirrhotic Patients in the Waiting List for Liver Transplantation[NCT00839358] | Phase 4 | 199 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children: a Pilot Study[NCT04043858] | 20 participants (Anticipated) | Interventional | 2020-06-05 | Recruiting | |||
Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations[NCT02799160] | 22 participants (Actual) | Observational | 2016-10-01 | Active, not recruiting | |||
Efficacy of Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin. A Multi-center Randomized Controlled Study[NCT00986817] | Phase 3 | 82 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
Vasoconstrictors as Alternatives to Albumin After Large Volume Paracentesis in Cirrhosis[NCT00108355] | Phase 4 | 29 participants (Actual) | Interventional | 2003-12-31 | Completed | ||
Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study[NCT05220891] | 60 participants (Anticipated) | Observational | 2023-01-11 | Not yet recruiting | |||
Prospective Study in the Use of the Alfapump® in the Treatment of Malignant Ascites[NCT04076566] | 0 participants (Actual) | Observational | 2020-05-31 | Withdrawn (stopped due to Update to clinical strategy - COVID impact) | |||
Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites Management: A Randomized Un-Blinded Pilot Study[NCT02975726] | 2 participants (Actual) | Interventional | 2017-01-31 | Completed | |||
The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients With Ascites and Activation of Sympathetic Nervous System: a Randomized Double-Blind Placebo Controlled Study.[NCT00356226] | 64 participants | Interventional | 2000-10-31 | Completed | |||
Acute Kidney Injury and Nonsteroidal Anti-inflammatory Drugs in Patients Undergoing High-risk Abdominal or Thoracic Surgery[NCT02553174] | 50 participants (Actual) | Observational | 2016-06-01 | Terminated (stopped due to unable to recruit sufficient patients to satisfy study protocols) | |||
Potential Role of Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Ascites in Cirrhotic Patients[NCT05999773] | 40 participants (Anticipated) | Observational | 2023-07-15 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Defined as an increase in Plasma Renin Activity (PRA) by >50% from baseline to a level > 4 ng/mL/h at post-paracentesis day (NCT00108355)
Timeframe: 6 days after paracentesis
Intervention | participants (Number) |
---|---|
Albumin (Control Group) | 2 |
Vasoconstrictor (Treatment Group) | 2 |
Comparison between Albumin (Control group) and Vasoconstrictor (Treatment group) (NCT00108355)
Timeframe: Variable depending on the patient, average 10 days
Intervention | days (Median) |
---|---|
Albumin (Control Group) | 10 |
Vasoconstrictor (Treatment Group) | 8 |
19 reviews available for aldosterone and Ascites
Article | Year |
---|---|
Effect of alpha agonists on the prevention of postparacentesis circulatory dysfunction in patients with refractory or recurrent ascites: a meta-analysis.
Topics: Aldosterone; Ascites; Humans; Midodrine; Shock | 2020 |
[Supportive care for malignant ascites in palliative phase: Place of paracentesis and diuretics].
Topics: Aldosterone; Ascites; Capillary Permeability; Diuretics; Furosemide; Humans; Hypertension, Portal; P | 2015 |
[The renin-angiotensin-aldosterone system in liver cirrhosis].
Topics: Aldosterone; Ascites; Humans; Liver; Liver Cirrhosis; Renin-Angiotensin System | 1983 |
[Disturbances of water and electrolyte equilibrium in liver disease: Part 2: Clinical picture (author's transl)].
Topics: Aldosterone; Ascites; Hepatitis; Humans; Hyperaldosteronism; Liver Cirrhosis; Liver Diseases; Water- | 1982 |
Pathogenesis of ascites and renal salt retention in cirrhosis.
Topics: Aldosterone; Animals; Ascites; Atrial Natriuretic Factor; Blood Volume; Diet, Sodium-Restricted; Diu | 1999 |
Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
Topics: Aldosterone; Animals; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Nitric Oxide; Peritoni | 2000 |
The kidney in cirrhosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Ascites; Diuretics; Hepatic Encephalopathy; Humans; Hypokalemi | 1976 |
Clinical applications of antimineralocorticoids.
Topics: Aldosterone; Angiotensin II; Ascites; Glucose; Heart Failure; Humans; Hypertension; Liver Cirrhosis; | 1988 |
The renin-angiotensin-aldosterone system in human hepatic cirrhosis.
Topics: Aldosterone; Ascites; Extracellular Space; Homeostasis; Humans; Liver Cirrhosis; Renin; Renin-Angiot | 1986 |
Sodium metabolism.
Topics: Adrenal Cortex Hormones; Adult; Aldosterone; Angiotensin II; Animals; Ascites; Biological Transport, | 1969 |
[Liver cirrhosis].
Topics: Aldosterone; Angiotensin II; Ascites; Humans; Juxtaglomerular Apparatus; Kidney; Liver; Liver Cirrho | 1971 |
Renal failure in advanced liver disease.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Ascites; Body Water; Hemodynamics; Humans; Kidney; | 1972 |
The rational management of ascites.
Topics: Albumins; Aldosterone; Animals; Ascites; Ascitic Fluid; Diet, Sodium-Restricted; Diuretics; Dogs; Dr | 1972 |
Hepatogenic ascites: pathogenesis and management.
Topics: Aldosterone; Ascites; Ascitic Fluid; Budd-Chiari Syndrome; Diet Therapy; Diet, Sodium-Restricted; Di | 1968 |
[Pathogenesis and treatment of the edema-ascites syndrome in patients with cirrhosis of the liver].
Topics: Adrenal Cortex Hormones; Aldosterone; Ascites; Diet Therapy; Edema; Humans; Liver Cirrhosis; Lymphat | 1967 |
Pathogenesis of ascites in cirrhosis of liver. II.
Topics: Aldosterone; Animals; Ascites; Ascitic Fluid; Ethanol; Heart Failure; Hemodynamics; Humans; Hyperald | 1969 |
[Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
Topics: Aldosterone; Ascites; Blood Proteins; Capillary Permeability; Diuretics; Edema; Electrolytes; Humans | 1969 |
Salt, water and adrenal steroid metabolism.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Ascites; Corticosterone; Diet, Sodium-Restricted; Dog | 1964 |
Review. Cirrhosis edema-ascites syndrome. The role of hormonal abnormalities in the pathogenesis.
Topics: Aldosterone; Ascites; Capillary Permeability | 1971 |
20 trials available for aldosterone and Ascites
Article | Year |
---|---|
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
Topics: Adult; Aged; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Follow-Up Studies; Humans; | 2018 |
Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Topics: Albumins; Aldosterone; Ascites; Creatinine; Female; Humans; Hypovolemia; Liver Cirrhosis; Male; Midd | 2014 |
Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
Topics: Aldosterone; Anti-Infective Agents; Ascites; Blood Pressure; Body Weight; Diuretics; Drug Therapy, C | 2016 |
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female | 2003 |
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Blood Volume; Creatinine; Drug Therapy, C | 2004 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Gastroi | 2006 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Dextrans; Diuretics; Female; Follow-Up Studies | 1994 |
Treatment of patients with IVCS and gross oedema and ascites with diuretic combination and ACE-inhibitors: relation to baseline PRA and PAC.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Ascites; Captopril; Diuretics; D | 1995 |
Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial.
Topics: Adult; Aged; Albumins; Aldosterone; Ascites; Blood Pressure; Cardiac Output; Female; Humans; Infusio | 1993 |
Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Amiloride; Ascites; Canrenoic Acid; Female; Humans; Kid | 1994 |
Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Ascites; Blood Pressure; Blood Urea Nitrogen; | 1996 |
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
Topics: Aldosterone; Ascites; Combined Modality Therapy; Diuretics; Dose-Response Relationship, Drug; Double | 1997 |
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
Topics: Aldosterone; Analysis of Variance; Ascites; Atrial Natriuretic Factor; Creatinine; Cyclic GMP; Femal | 1997 |
Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.
Topics: Adult; Aged; Aldosterone; Analysis of Variance; Ascites; Blood Pressure; Blood Volume; Cardiac Outpu | 1998 |
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
Topics: Aldosterone; Ascites; Blood Pressure; Diuresis; Electrolytes; Gastrointestinal Agents; Glomerular Fi | 1999 |
The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis.
Topics: Aldosterone; Antihypertensive Agents; Ascites; Blood Volume; Homeostasis; Humans; Liver Cirrhosis; L | 2002 |
Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Dextrans; Female; Follow-Up Studies; Hospitali | 1990 |
Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Humans; Inhalation; Liver Cirrhosis; | 1991 |
163 other studies available for aldosterone and Ascites
Article | Year |
---|---|
Can we predict early renal impairment in pediatric cirrhosis?
Topics: Acute Kidney Injury; Albumins; Aldosterone; Ascites; Child; End Stage Liver Disease; Female; Humans; | 2022 |
Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Biomarkers; C-Reactive Protein; Creatinine; Diuretics; Etilefrine; Furosemide; | 2022 |
[Effect of Gansui Banxia Tang plus-minus Gansui and Gancao anti-drug combination that preferred dose close to clinical application on diuretic effect in malignant ascites rats].
Topics: Aldosterone; Angiotensin II; Animals; Ascites; Body Weight; Diuretics; Dose-Response Relationship, D | 2014 |
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Topics: Administration, Intravenous; Aged; Albumins; Aldosterone; Angiotensin II; Ascites; Cardiovascular Di | 2016 |
Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
Topics: Aged; Aldosterone; Angiotensinogen; Angiotensins; Ascites; Ascitic Fluid; Female; Humans; Liver Cirr | 2008 |
Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Biomarkers; Diuretics; Drug Therapy, Combinati | 2011 |
Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites.
Topics: Aldosterone; Amino Acids; Ascites; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Hu | 2002 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
Effect of amphenone therapy of urinary excretion of aldosterone and sodium in hepatic cirrhosis with ascites.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Propiophenones; Sodium; Sodium, Dietary | 1957 |
Effects of a body cast on aldosterone and sodium excretion in dogs with experimental ascites.
Topics: Aldosterone; Animals; Ascites; Body Fluids; Dogs; Ions; Sodium; Sodium, Dietary | 1958 |
The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Spironolacton | 1958 |
[Aldosterone in liver cirrhosis].
Topics: Aldosterone; Ascites; Digestion; Humans; Liver Cirrhosis | 1958 |
The effect of prednisone and amphenone on fluid and electrolyte balance and on aldosterone excretion of patients with cirrhosis and ascites.
Topics: Aldosterone; Ascites; Body Fluids; Humans; Liver Cirrhosis; Prednisone; Propiophenones; Water-Electr | 1959 |
Sodium and water diuresis in cirrhotic patients with intractable ascites following chemical inhibition of aldosterone synthesis.
Topics: Aldosterone; Ascites; Diuresis; Humans; Liver Cirrhosis; Pyridines; Sodium; Sodium, Dietary | 1960 |
[Trials of treatment of cirrhotic ascites with a spirolactone. Apropos of 7 cases].
Topics: Aldosterone; Ascites; Diuretics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Organic Ch | 1961 |
Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Spironolacton | 1961 |
Combined diuretic and steroid therapy in cirrhosis with ascites.
Topics: Adrenal Cortex Hormones; Aldosterone; Ascites; Diuretics; Liver Cirrhosis; Mineralocorticoid Recepto | 1960 |
An aldosterone antagonist and diuretics in the treatment of chronic oedema and ascites.
Topics: Aldosterone; Antihypertensive Agents; Ascites; Chlorothiazide; Diuretics; Edema; Mineralocorticoid R | 1960 |
[Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
Topics: Aldosterone; Ascites; Diuretics; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Sp | 1962 |
Observations on the mechanism and treatment of ascites in hepatic cirrhosis.
Topics: Aldosterone; Ascites; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists | 1962 |
[Spirolactone (Aldactone) in ascites caused by liver cirrhosis].
Topics: Aldosterone; Ascites; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Spironolactone | 1962 |
Long-term medical management and complications of 'resistant' ascites.
Topics: Aldosterone; Ascites; Diuretics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists | 1961 |
[Treatment of the hydrosaline retention in hepatic cirrhosis with spironolactone].
Topics: Aldosterone; Ascites; Diuretics; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Sp | 1961 |
Significance of aldosterone antagonism in the treatment of edema and ascites.
Topics: Aldosterone; Antihypertensive Agents; Ascites; Chlorothiazide; Diuretics; Edema; Humans; Hydrochloro | 1962 |
[Diuretic effect of spironolactone (Sc-9420) in patients with cirrhosis of the liver with ascites].
Topics: Aldosterone; Ascites; Diuretics; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Sp | 1961 |
[ON THE MECHANISM OF ACTION OF THE DIURETIC ACTIVITY OF 2,4,7-TRIAMINO-6-PHENYL-PTERIDINE (TRIAMTERENE)].
Topics: Aldosterone; Ascites; Blood Chemical Analysis; Body Weight; Diuretics; Heart Failure; Humans; Hypera | 1963 |
EFFECT OF SODIUM ON JUXTAGLOMERULAR INDEX AND ZONA GLOMERULOSA IN EXPERIMENTAL NEPHROSIS.
Topics: Adrenal Glands; Aldosterone; Angiotensins; Ascites; Blood Pressure; Blood Pressure Determination; Bl | 1963 |
[DIURESIS, ELECTROLYTES AND ALDOSTERONE AFTER TRIAMTERENE: FINDINGS IN THE SO-CALLED "REFRACTORY EDEMAS" OF PATIENTS WITH HEART DISEASE AND LIVER CIRRHOSIS].
Topics: Aldosterone; Ascites; Diuresis; Diuretics; Edema; Electrolytes; Heart Failure; Liver Cirrhosis; Pter | 1963 |
[USE OF AN INHIBITOR OF ALDOSTERONE SYNTHESIS (SU-4885, METOPIRONE) IN SOME REFRACTORY EDEMATOUS STATES].
Topics: Aldosterone; Ascites; Edema; Heart Failure; Hepatitis; Ketones; Liver Cirrhosis; Metyrapone; Mineral | 1963 |
[NATRIURETIC DRUGS].
Topics: Acetazolamide; Aldosterone; Ascites; Chlorothiazide; Dexamethasone; Diabetes Insipidus; Diuresis; Di | 1963 |
[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
Topics: Adrenocorticotropic Hormone; Aldosterone; Ascites; Body Fluids; Classification; Dexamethasone; Extra | 1964 |
[ALTERATIONS IN THE EXCRETION OF ALDOSTERONE AND ELECTROLYTES IN HEPATIC CIRRHOSIS, CONGESTIVE HEART FAILURE AND IDIOPATHIC EDEMAS].
Topics: 17-Ketosteroids; Aldosterone; Ascites; Edema; Electrolytes; Heart Failure; Humans; Liver Cirrhosis; | 1964 |
EXPERIMENTAL ASCITES. VI. THE EFFECTS OF HEPATIC VENOUS OUTFLOW OBSTRUCTION AND ASCITES ON ALDOSTERONE SECRETION.
Topics: Adrenal Glands; Aldosterone; Ascites; Blood; Blood Pressure; Budd-Chiari Syndrome; Dogs; Hepatic Vei | 1964 |
THE ROLE OF ADRENALECTOMY IN THE MANAGEMENT OF INTRACTABLE ASCITES.
Topics: Adrenalectomy; Aldosterone; Ascites; Cortisone; Diet; Diet Therapy; Humans; Hydrocortisone; Liver Ci | 1964 |
THE EFFECT IN VITRO OF ESTRONE AND BRADYKININ ON A NUCLEAR ABNORMALITY IN A HAMSTER ASCITES TUMOR.
Topics: Adrenocorticotropic Hormone; Aldosterone; Arginine Vasopressin; Ascites; Blood; Bradykinin; Cell Div | 1964 |
[ALDOSTERONE INHIBITORS IN THE TREATMENT OF EDEMAS].
Topics: Aldosterone; Ascites; Drug Therapy; Edema; Geriatrics; Heart Failure; Humans; Liver Cirrhosis; Miner | 1964 |
ROLE OF LIVER DAMAGE IN INCREASING ALDOSTERONE EXCRETION IN PATIENTS OF CIRRHOSIS AND ASCITES.
Topics: Aldosterone; Ascites; Body Fluids; Humans; Liver; Liver Cirrhosis; Liver Diseases; Punctures; Urine | 1964 |
DISTRIBUTION OF BODY SODIUM, POTASSIUM, AND WATER AND THE EXCRETION OF ALDOSTERONE IN DOGS WITH SPONTANEOUS HEART FAILURE.
Topics: Aldosterone; Animals; Ascites; Dog Diseases; Dogs; Edema; Heart Failure; Humans; Mitral Valve Insuff | 1965 |
[EFFECT OF BLOCKADE OF THE PERIPHERAL ACTION OF ALDOSTERONE ON THE EFFECT OF ANGIOTENSIN IN LIVER CIRRHOSIS].
Topics: Aldosterone; Angiotensins; Ascites; Diuresis; Drug Therapy; Humans; Liver Cirrhosis | 1964 |
URINARY ALDOSTERONE EXCRETION IN CIRRHOSIS OF LIVER WITH ASCITES AND ITS RELATIONSHIP WITH PLASMA VOLUME AND ELECTROLYTES.
Topics: Aldosterone; Ascites; Electrolytes; Humans; Liver Cirrhosis; Plasma Volume; Urine | 1965 |
PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.
Topics: Aldosterone; Angiotensin II; Angiotensins; Ascites; Blood Pressure; Body Fluids; Dexamethasone; Huma | 1965 |
Hyperaldo-steronism in liver disease. The treatment of refractory ascites by adrenalectomy and by the administration of spirolactones.
Topics: Adrenalectomy; Aldosterone; Ascites; Humans; Lactones; Liver Diseases; Spironolactone | 1960 |
Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide).
Topics: Aldosterone; Ascites; Chlorothiazide; Diuretics; Mannitol; Mineralocorticoid Receptor Antagonists; S | 1960 |
[Treatment of the ascites and edema of cirrhotics by spironolactone].
Topics: Aldosterone; Ascites; Diuretics; Edema; Edetic Acid; Mineralocorticoid Receptor Antagonists; Spirono | 1962 |
[Spirolactone treatment of liver cirrhosis with edema and ascites].
Topics: Aldosterone; Ascites; Edema; Edetic Acid; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; O | 1962 |
Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
Topics: Abdomen; Aldosterone; Ascites; Ascitic Fluid; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Ni | 2004 |
The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.
Topics: Alberta; Albumins; Aldosterone; Analysis of Variance; Ascites; Creatine; Female; Humans; Male; Metab | 2009 |
Diuretics.
Topics: Aldosterone; Ascites; Chlorothiazide; Diuretics; Edema; Ethacrynic Acid; Furosemide; Humans; Organom | 1967 |
Exchange of aldosterone between plasma and thoracic duct lymph.
Topics: Aldosterone; Animals; Arthritis, Rheumatoid; Ascites; Carbon Isotopes; Dogs; Edema; Esophageal and G | 1967 |
[Effect of renal hemodynamics, aldosterone and other factors on ascites formation in schistosomiasis].
Topics: Adult; Aldosterone; Ascites; Electrolytes; Female; Humans; Kidney; Male; Middle Aged; Renal Circulat | 1983 |
Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.
Topics: Aldosterone; Arginine Vasopressin; Ascites; Body Water; Creatinine; Diuresis; Humans; Hyponatremia; | 1983 |
Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.
Topics: Adult; Aged; Aldosterone; Ascites; Blood Volume; Female; Humans; Kidney Function Tests; Liver Cirrho | 1983 |
Sodium and fluid retention in hepatic cirrhosis: a role for circulating hormones?
Topics: Aldosterone; Ascites; Body Fluids; Diuretics; Hormones; Humans; Liver Cirrhosis; Natriuresis; Plasma | 1984 |
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Ascites; Body Water; Female; Humans; Kidney; Liver C | 1982 |
[Estimation of plasma renin, angiotensin II and urinary aldosterone in patients with cirrhosis of liver and its clinical significance].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Age | 1982 |
Renin-angiotensin-aldosterone in cirrhotic ascites.
Topics: Aldosterone; Angiotensin II; Ascites; Humans; Liver Cirrhosis; Renin | 1980 |
[Cirrhotic ascites and the renin-angiotensin system].
Topics: Aldosterone; Ascites; Female; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Renin | 1980 |
Renin-angiotensin-aldosterone system in cirrhosis.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Ascites; Blood Volume; Edema; Extracellular Space; | 1980 |
Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects.
Topics: Aldosterone; Ascites; Creatinine; Diet, Sodium-Restricted; Follow-Up Studies; Hemodynamics; Humans; | 1981 |
Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.
Topics: Adult; Aldosterone; Ascites; Female; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Male; Midd | 1981 |
[Treatment of refractory ascites by means of the LeVeen shunt].
Topics: Aldosterone; Ascites; Body Weight; Creatinine; Diuresis; Female; Humans; Male; Middle Aged; Peritone | 1981 |
The acute effects of sustained volume expansion on the renin-aldosterone system and renal function in human hepatic ascites.
Topics: Aldosterone; Ascites; Hemodynamics; Humans; Kidney; Liver Diseases; Peritoneovenous Shunt; Renin; Ur | 1981 |
Control of malignant ascites with spironolactone.
Topics: Abdominal Neoplasms; Aldosterone; Ascites; Breast Neoplasms; Female; Humans; Male; Renin; Sodium; Sp | 1982 |
[Physiopathology and therapy of the ascites in liver cirrhosis].
Topics: Aldosterone; Ascites; Diet, Sodium-Restricted; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Sod | 1982 |
[What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?].
Topics: Aldosterone; Ascites; Diet, Sodium-Restricted; Diuretics; Humans; Hyperaldosteronism; Liver Cirrhosi | 1981 |
Hyperaldosteronism associated with liver metastases.
Topics: Aldosterone; Alkaline Phosphatase; Ascites; Bilirubin; Edema; Female; Humans; Hyperaldosteronism; Li | 1980 |
Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Drug Therapy, Combination; Female; Humans; Liver Cirrh | 1980 |
Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Aprotinin; Ascites; Blood Pressure; Female; Glomerular Fil | 1994 |
Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; | 1995 |
Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Humans; Kidney; Liver Cirrhosis; Male; | 1994 |
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
Topics: Adult; Aged; Aldosterone; Ascites; Female; Hemodynamics; Humans; Kidney; Liver; Liver Transplantatio | 1995 |
[ANP in the cirrhotic patient. A clinical contribution].
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Female; Humans; Liver Cirrhosis; Male; Middl | 1994 |
Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
Topics: Adult; Aldosterone; Ascites; Bile Ducts, Intrahepatic; Evaluation Studies as Topic; Female; Humans; | 1995 |
Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis.
Topics: Adult; Aldosterone; Ascites; Blood Coagulation; Blood Component Removal; Female; Humans; Kidney; Liv | 1994 |
Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.
Topics: Abdomen; Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Circulation; Echocardio | 1994 |
Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Blood Pressure; | 1994 |
Central blood volume in cirrhosis: measurement with radionuclide angiography.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Blood Volume D | 1994 |
The hyponatremia of neonatal urinary ascites: clinical observations, experimental confirmation and proposed mechanism.
Topics: Aldosterone; Animals; Ascites; Bicarbonates; Blood Urea Nitrogen; Chlorides; Female; Humans; Hyponat | 1993 |
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Creatinine; Cyclic GMP; Female; Hemato | 1993 |
Atrial natriuretic peptide and hemodynamic changes after concentrated ascitic fluid reinfusion in cirrhotic patients.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Cardiac Output; Diuresis | 1993 |
Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Hemodynamics; Humans; Hypertension, Portal; Isosorb | 1993 |
Relation of endothelins to volume regulating neurohumoral systems in patients with cirrhosis of the liver.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Diuretic | 1995 |
Urinary excretion of urodilatin in patients with cirrhosis.
Topics: Aldosterone; Analysis of Variance; Ascites; Atrial Natriuretic Factor; Biomarkers; Creatinine; Femal | 1996 |
Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.
Topics: Aged; Aldosterone; Ascites; Creatinine; Diuretics; Female; Hepatic Encephalopathy; Humans; Hypertens | 1997 |
Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Topics: Aged; Albumins; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Cardiac Output; Diure | 1997 |
Plasma adrenomedullin levels in patients with hepatic cirrhosis.
Topics: Adrenomedullin; Adult; Aged; Aldosterone; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Age | 1997 |
Urinary endothelin-like immunoreactivity in patients with cirrhosis.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Endothelins; Female; Hepatorenal Syndrome; H | 1997 |
Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
Topics: Aldosterone; Animals; Aorta; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Body Water; C | 1998 |
Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Blood Pressure; Epoprostenol; Female; Glucagon; Heart Rate; Hemodynamics; Huma | 1998 |
Noninvasive assessment of spontaneous baroreflex sensitivity in patients with liver cirrhosis.
Topics: Aldosterone; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Baroreflex; Blood Pressure; C | 1998 |
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Topics: Aged; Aldosterone; Ascites; Blood Pressure; Endotoxins; Female; Hepatic Encephalopathy; Humans; Inte | 1999 |
Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Creatinine; Female; Follow-Up Studies; Humans; | 1999 |
Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis.
Topics: Aldosterone; Ascites; Female; Hemodynamics; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Age | 2001 |
[Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Topics: Aldosterone; Ascites; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hyperkalemi | 2001 |
Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.
Topics: Aldosterone; Ascites; Humans; Kidney; Liver Cirrhosis; Regional Blood Flow; Renin; Sodium | 1979 |
[The renin-angiotensin-aldosterone system in parenchymatous liver diseases].
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Angiotensinogen; Ascites; Blood Pressure; Endopept | 1976 |
Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals | 1979 |
The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Body Weight; Budd-Chiari Syndrome; Cardiac Output; Diuresis; Drai | 1979 |
Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.
Topics: Adult; Aldosterone; Ascites; Chronic Disease; Creatinine; Female; Humans; Ibuprofen; Indomethacin; K | 1979 |
Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites.
Topics: Aldosterone; Angiotensin II; Ascites; Blood Pressure; Humans; Liver Cirrhosis; Renin | 1979 |
Renal sodium retention in cirrhosis: relation to aldosterone and nephron site.
Topics: Aldosterone; Ascites; Humans; Kidney; Liver Cirrhosis; Nephrons; Sodium | 1979 |
[Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Ascites; Electrolytes; Female; Humans; Hypera | 1979 |
Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion.
Topics: Adult; Aldosterone; Angiotensin II; Ascites; Blood Volume; Female; Humans; Infusions, Parenteral; Li | 1979 |
Peritoneovenous (LeVeen) shunt. Control of renin-aldosterone system in cirrhotic ascites.
Topics: Adult; Aldosterone; Ascites; Humans; Jugular Veins; Liver Cirrhosis; Male; Peritoneal Cavity; Renin; | 1978 |
Sodium retention in dogs with cirrhosis and ascites: efferent mechanisms.
Topics: Aldosterone; Animals; Ascites; Blood Pressure; Cardiac Output; Denervation; Dogs; Estrogens; Female; | 1977 |
Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensinogen; Ascites; Diuretics; Humans; Liver Cirrhos | 1978 |
Improved renal function and inhibition of renin and aldosterone secretion following peritoneovenous (LeVeen) shunt.
Topics: Aldosterone; Angiotensinogen; Ascites; Creatinine; Diuresis; Fatty Liver; Glomerular Filtration Rate | 1978 |
Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Ascites; Blood Pressure; Depression, Chemical; Female; Hum | 1978 |
Renin-angiotensin-aldosterone system in rabbits with thoracic caval constriction.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Ascites; Blood Pressure; Corticosterone; Edema | 1977 |
[Pathogenesis and therapy of edematous diseases. 1. Pathogenesis of edematous diseases].
Topics: Aldosterone; Angiotensin II; Ascites; Capillary Permeability; Catecholamines; Edema; Edema, Cardiac; | 1977 |
[Aldosterone and renin in liver cirrhosis with ascites].
Topics: Aldosterone; Ascites; Furosemide; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Renin; Spiron | 1977 |
[Humoral and hormonal changes in portal hypertension].
Topics: Aldosterone; Angiotensin II; Ascites; Blood Pressure; Hypertension, Portal; Renin; Vasoconstrictor A | 1976 |
Studies of renin and aldosterone in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Renin; Sodium | 1975 |
Plasma atrial natriuretic peptide and renin-aldosterone in patients with cirrhosis and ascites: basal levels, changes during daily activity and nocturnal diuresis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Bilirubin; Blood Pressure; Circadian Rhythm; Creati | 1992 |
Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis.
Topics: Aldosterone; Analysis of Variance; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Biomark | 1992 |
Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol.
Topics: Aged; Aldosterone; Ascites; Aspartate Aminotransferases; Atrial Natriuretic Factor; Bilirubin; Human | 1992 |
Plasma levels of brain natriuretic peptide in patients with cirrhosis.
Topics: Alanine Transaminase; Aldosterone; Alkaline Phosphatase; Ascites; Aspartate Aminotransferases; Bilir | 1992 |
Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Female; Hemodynamics; Humans; Kidney Tubules | 1991 |
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Diuretics; Drug Resistance; Electrolytes; Fema | 1991 |
Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
Topics: Adult; Aged; Aldosterone; Ascites; Blood Pressure; Blood Volume; Diet, Sodium-Restricted; Female; Ho | 1991 |
Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
Topics: Aged; Aldosterone; Ascites; Blood Pressure; Body Water; Creatine; Electrolytes; Glomerular Filtratio | 1991 |
[The clinical importance of determining aldosterone in the ascitic fluid].
Topics: Aldosterone; Ascites; Ascitic Fluid; Humans; Liver Cirrhosis; Radioimmunoassay | 1990 |
Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance.
Topics: Aldosterone; Ascites; Female; Glomerular Filtration Rate; Humans; Kidney Tubules; Lithium; Liver Cir | 1990 |
Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, A | 1990 |
[Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading].
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Extracellular Space; Humans; Hypertension; Kidney; | 1990 |
[Reaction of the cardiovascular and humoral system to acute hypervolemia in patients with liver cirrhosis].
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Female; Hemodynamics; Humans; | 1989 |
Atrial natriuretic peptide-renin-aldosterone system in cirrhosis of the liver: circadian study.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Circadian Rhythm; Female; Humans; Liver Cirr | 1989 |
Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Pressure; Catecholamines; Female | 1989 |
Heterogeneous renal responses to atrial natriuretic factor. I. Chronic caval dogs.
Topics: Aldosterone; Animals; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Diuresis; Dogs; Fema | 1989 |
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Cyclic GMP; Female; Glomerular Filtrat | 1989 |
Clinical, biochemical, and hormonal changes after a single, large-volume paracentesis in cirrhosis with ascites.
Topics: Aged; Aldosterone; Arginine Vasopressin; Ascites; Female; Humans; Kidney Function Tests; Liver Cirrh | 1989 |
[Changes in antidiuretic hormone (ADH) in liver cirrhosis with resistant ascites].
Topics: Aged; Aldosterone; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Potassium; Renin; So | 1989 |
[Clinical assessment of electrolyte metabolism and the renin-aldosterone system in patients with liver cirrhosis and ascites].
Topics: Adult; Aldosterone; Ascites; Electrolytes; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis; Live | 1989 |
Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation.
Topics: Aged; Aldosterone; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Female; Humans; Liver C | 1988 |
Increased renin release by exogenous prostaglandin E1 in liver cirrhosis with and without ascites.
Topics: Adult; Aged; Aldosterone; Alprostadil; Ascites; Humans; Liver Cirrhosis, Experimental; Liver Functio | 1988 |
Renin, aldosterone and arginine vasopressin in patients with liver cirrhosis: the influence of ascites retransfusion.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Ascites; Female; Hepatitis, Chronic; Humans; Liver C | 1986 |
Urinary kallikrein excretion in chronic liver disease and effect of indomethacin.
Topics: Aldosterone; Ascites; Bilirubin; Cholinesterases; Chronic Disease; Depression, Chemical; Humans; Ind | 1986 |
The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
Topics: Aldosterone; Ascites; Creatinine; Furosemide; Humans; Kidney; Liver Cirrhosis; Natriuresis; p-Aminoh | 1986 |
[Surgical treatment of the ascitic patient using LeVeen peritoneojugular shunt. Personal case reports].
Topics: Aldosterone; Ascites; Female; Humans; Jugular Veins; Liver Cirrhosis; Male; Middle Aged; Peritoneove | 1986 |
Effect of chemical sympathectomy on renal hydroelectrolytic handling in dogs with chronic caval constriction.
Topics: Aldosterone; Animals; Ascites; Constriction; Diuresis; Dogs; Kidney; Natriuresis; Renin; Sympathecto | 1986 |
Hyporeninemic hypoaldosteronism in a patient with cirrhosis and ascites.
Topics: Aldosterone; Ascites; Diabetic Nephropathies; Female; Humans; Liver Cirrhosis; Middle Aged; Renin | 1986 |
Clinical and hormonal conditions associated with sodium retention in cirrhotic patients with ascites. Evaluation by univariate and multivariate analyses.
Topics: Adult; Aged; Aldosterone; Arginine; Ascites; Blood Pressure; Female; Humans; Liver Cirrhosis; Male; | 1987 |
Sodium excretion in dogs with low-grade caval constriction: role of hepatic nerves.
Topics: Aldosterone; Animals; Ascites; Biopsy; Blood Pressure; Cardiac Output; Constriction; Denervation; Do | 1987 |
Angiotensin-induced natriuresis in cirrhosis in the absence of endogenous aldosterone secretion.
Topics: Aldosterone; Angiotensin II; Ascites; Female; Humans; In Vitro Techniques; Liver Cirrhosis; Middle A | 1966 |
The effects of aldosterone and angiotensin on renal function.
Topics: Adult; Aldosterone; Angiotensin II; Ascites; Edema; Female; Humans; In Vitro Techniques; Kidney; Kid | 1966 |
[Angiotensin intradermoreaction in patients with liver cirrhosis in the ascitic phase. Results and interpretation in relation to the pathogenesis of the altered hydrosaline metabolism in cirrhogenic liver diseases].
Topics: Aldosterone; Angiotensin II; Ascites; Diabetes Insipidus; Heart Failure; Humans; Hypertension; Jaund | 1966 |
[Renin-angiotensin system in patients with circulatory insufficiency].
Topics: Aldosterone; Angiotensin II; Ascites; Coronary Disease; Diuretics; Edema; Endopeptidases; Humans; Ju | 1968 |
Use of diuretics in liver disease with ascites.
Topics: Aldosterone; Angiotensin II; Ascites; Diuretics; Edema; Hemodynamics; Humans; Kidney; Liver Diseases | 1970 |
[Angiotensin-aldosterone interrelations in hepatic cirrhosis].
Topics: Aldosterone; Angiotensin II; Ascites; Edema; Humans; Liver Cirrhosis; Natriuresis; Potassium | 1970 |
[Angiotensin infusion test in liver cirrhosis].
Topics: Aldosterone; Angiotensin II; Ascites | 1971 |
Effect of prostaglandin A 1 on renal and adrenal function in man.
Topics: Adrenal Glands; Aldosterone; Ascites; Blood Pressure; Calcium; Creatinine; Cyclic AMP; Edema; Glomer | 1972 |
Angiotensin. II. Important role in the maintenance of arterial blood pressure.
Topics: Adrenal Glands; Alanine; Aldosterone; Angiotensin II; Animals; Ascites; Blood Pressure; Dogs; Female | 1973 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, So | 1973 |
[Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
Topics: Aldosterone; Angiotensin II; Ascites; Capillary Permeability; Hemodynamics; Humans; Hyperaldosteroni | 1974 |
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
Topics: Acetazolamide; Adult; Aldosterone; Ascites; Female; Furosemide; Heart Failure; Heart Valve Diseases; | 1968 |
Ovarian hyperstimulation syndrome. Report of a case with notes on pathogenesis and treatment.
Topics: Adult; Aldosterone; Ascites; Blood Cell Count; Blood Coagulation Tests; Body Weight; Chorionic Gonad | 1972 |
Clinical studies on the role of aldosterone concerning the edema formation in chronic congestive heart failure.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adult; Aged; Aldosterone; Ascites; Chromatography; Diuretics; | 1971 |
[Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Female; Furosemide; Humans; Hydrochlorothiazide; Liver | 1970 |
Studies on the mechanism of experimental congestive heart failure in dogs.
Topics: Aldosterone; Aminohippuric Acids; Animals; Aorta; Ascites; Blood Pressure; Dogs; Edema; Female; Glom | 1970 |
Spironolactone diuresis in patients with cirrhosis and ascites.
Topics: Alcoholism; Aldosterone; Ascites; Humans; Liver Cirrhosis; Potassium; Sodium; Spironolactone | 1970 |
The effect of spironolactone on sodium transport in the absence of aldosterone.
Topics: Aldosterone; Animals; Ascites; Biological Transport; Carcinoma; Depression, Chemical; Erythrocytes; | 1970 |
Amiloride. A potassium-sparing natriuretic agent.
Topics: Acetazolamide; Aldosterone; Ammonia; Ascites; Bicarbonates; Blood Pressure; Chlorides; Chlorothiazid | 1968 |
Increased sodium reabsorption in the proximal and distal tubule of caval dogs.
Topics: Adsorption; Aldosterone; Animals; Ascites; Diuresis; Dogs; Female; Kidney Tubules; Mannitol; Potassi | 1969 |